We apologize! The document was not able to download due to an unknown error. Our team has been notified and we will fix it as soon as possible. Fill out the form below, and we will send you the document as soon as we can!
LACTEL® 50:50 DL-PLGE, IV 0.15-0.25
LACTEL® 50:50 DL-PLGE, IV 0.15-0.25 is a biodegradable PLGA-based copolymer made up of a 50:50 ratio of D,L-lactide and glycolide with an inherent viscosity of 0.15─0.25 dL/g in HFIP. LACTEL® 50:50 DL-PLGE, IV 0.15-0.25 is non-GMO certified and contains no added preservatives for pharmaceautical and medical applications. LACTEL® 50:50 DL-PLGE, IV 0.15-0.25 offers a degredation period of 3 months.
LACTEL® 50:50 DL-PLGE, IV 0.15-0.25 is a functional excipient from Evonik recommended for parenteral controlled release systems, long acting injectable formulations, and human generic drug formulations. Manufactured using a streamlined process to produce a PLGA copolymer containing 50% Glycolide and 50% D,L-lactide, LACTEL® 50:50 DL-PLGE, IV 0.15-0.25 offers a cost effective solution for the formulating of high-quality pharmaceutical products that meet market demands. It is compatible with various substances, including proteins, peptides, nanoparticles, and microparticles, and is 100% bioabsorbable for complete metabolization in the body.
Specifications
Physical state: Solid Form: Granules Color: White to light tan Inherent viscosity (IV) dL/g: 0.15─0.25 (in HFIP) Degradation time: <3 months Density (g/mL): 1.34 Tensile Strength (psi): 6000─8000 Elongation (%): 3─10 Modulus (psi): 2─4x10⁵ CAS No. 26780-50-7
Primary Chemistry: Poly(DL-lactide-co-glycolide)
Features & Benefits
50:50 ratio of D,L-Lactide and Glycolide Ester end group 3-month degradation time Biodegradable Ideal for terminal sterilization Bioabsorbable excipient Suitable for use with small molecules, peptides, proteins, and other substances Non-GMO No added preservatives Cost effective
Applications
Human generic drug formulations Long-acting injectable formulations Price sensitive applications veterinary medicine
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Thank you
Thank you for your inquiry and interest in ChemPoint. We will respond to you shortly.
ChemPoint will not under any circumstances release personal user information to individuals or companies. All information collection is solely used to support ChemPoint customers service communications. Read our Privacy Notice.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Document Download
The document currently is provided in the following languages from the supplier at this time.
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region:
English - United States
Hi, let us know if you have any questions as you visit our website.
